Market Cap 592.57M
Revenue (ttm) 18.14M
Net Income (ttm) -72.85M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 649,900
Avg Vol 936,122
Day's Range N/A - N/A
Shares Out 188.72M
Stochastic %K 2%
Beta 1.98
Analysts Strong Sell
Price Target $4.50

Company Profile

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 1 and phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the poten...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 469 0914
Address:
701 Veterans Circle, Warminster, United States
1iquid
1iquid Dec. 25 at 8:43 AM
💎 Liquid® Live Actionable Trade Asset: $ABUS Contracts: $ABUS January 15, 2027 $5 Calls Scale in: $1.35- $1.65 Scale out: $5.25-$9.00 Profit Potential : 148% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 24 at 9:01 PM
Enter: $ABUS Calls Strike Price: $5 Expiry Date: JAN 16 2026 Buy in Price: $0.24 - $0.25 Sell Price: $0.48 Profit : +101% (Turn every $1 into $2.01) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Shortsales
Shortsales Dec. 24 at 3:58 PM
1 · Reply
NakdEnergy
NakdEnergy Dec. 24 at 2:57 PM
$ABUS how much of $ROIV’s 190% launch is on our back?
1 · Reply
NakdEnergy
NakdEnergy Dec. 24 at 1:02 PM
$ABUS $ROIV up 90+ % in 1 year? Must have something to do with them basically owning/running $ABUS….
1 · Reply
CopperCap
CopperCap Dec. 24 at 11:48 AM
$ABUS Future price discovery depends on how timelines compress uncertainty rather than extend speculation. Delays or dilution could materially reshape the risk profile.
0 · Reply
Theverypatientone
Theverypatientone Dec. 24 at 2:12 AM
$ABUS again not less than 12% royalty rate on 130B sales, not considering the ones falling under 1498 whuch are probably 150 200 million dollars. so at minimum $5B to ABUS alone.
2 · Reply
Shortsales
Shortsales Dec. 23 at 11:32 PM
2 · Reply
JB6791
JB6791 Dec. 23 at 9:44 PM
$MRNA $PFE time to pay up crooks $ABUS
0 · Reply
Thepatientone
Thepatientone Dec. 23 at 8:50 PM
$ABUS - I have not posted in a while but I have said all I could. I do not want to settle at this point with $MRNA . We waited so long so might as well get a jury to punish the culprit like it should. ABUS long and strong.
3 · Reply
Latest News on ABUS
Arbutus, Burford Capital, And Cadiz With Chris DeMuth Jr.

Jan 30, 2025, 3:40 PM EST - 11 months ago

Arbutus, Burford Capital, And Cadiz With Chris DeMuth Jr.

BUR CDZI


Arbutus Provides 2025 Corporate and Financial Update

Jan 13, 2025, 7:30 AM EST - 1 year ago

Arbutus Provides 2025 Corporate and Financial Update


Arbutus to Present at Jefferies London Healthcare Conference

Nov 14, 2024, 7:30 AM EST - 1 year ago

Arbutus to Present at Jefferies London Healthcare Conference


Arbutus to Participate in Two Upcoming Investor Conferences

Sep 3, 2024, 7:30 AM EDT - 1 year ago

Arbutus to Participate in Two Upcoming Investor Conferences


Arbutus Distributors Ltd. News Release

Jun 3, 2024, 9:50 AM EDT - 1 year ago

Arbutus Distributors Ltd. News Release


Arbutus to Present Imdusiran Data at EASL Congress 2024

May 22, 2024, 2:00 AM EDT - 1 year ago

Arbutus to Present Imdusiran Data at EASL Congress 2024


1iquid
1iquid Dec. 25 at 8:43 AM
💎 Liquid® Live Actionable Trade Asset: $ABUS Contracts: $ABUS January 15, 2027 $5 Calls Scale in: $1.35- $1.65 Scale out: $5.25-$9.00 Profit Potential : 148% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 24 at 9:01 PM
Enter: $ABUS Calls Strike Price: $5 Expiry Date: JAN 16 2026 Buy in Price: $0.24 - $0.25 Sell Price: $0.48 Profit : +101% (Turn every $1 into $2.01) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Shortsales
Shortsales Dec. 24 at 3:58 PM
1 · Reply
NakdEnergy
NakdEnergy Dec. 24 at 2:57 PM
$ABUS how much of $ROIV’s 190% launch is on our back?
1 · Reply
NakdEnergy
NakdEnergy Dec. 24 at 1:02 PM
$ABUS $ROIV up 90+ % in 1 year? Must have something to do with them basically owning/running $ABUS….
1 · Reply
CopperCap
CopperCap Dec. 24 at 11:48 AM
$ABUS Future price discovery depends on how timelines compress uncertainty rather than extend speculation. Delays or dilution could materially reshape the risk profile.
0 · Reply
Theverypatientone
Theverypatientone Dec. 24 at 2:12 AM
$ABUS again not less than 12% royalty rate on 130B sales, not considering the ones falling under 1498 whuch are probably 150 200 million dollars. so at minimum $5B to ABUS alone.
2 · Reply
Shortsales
Shortsales Dec. 23 at 11:32 PM
2 · Reply
JB6791
JB6791 Dec. 23 at 9:44 PM
$MRNA $PFE time to pay up crooks $ABUS
0 · Reply
Thepatientone
Thepatientone Dec. 23 at 8:50 PM
$ABUS - I have not posted in a while but I have said all I could. I do not want to settle at this point with $MRNA . We waited so long so might as well get a jury to punish the culprit like it should. ABUS long and strong.
3 · Reply
Biibrian
Biibrian Dec. 23 at 8:33 PM
$ABUS why is $MRNA down 7% today?
0 · Reply
Alfalcon
Alfalcon Dec. 23 at 3:34 PM
$ABUS This is my seventh card to y'all. Lol. Enjoy. 2026 will be exciting times.
6 · Reply
SpaceCityKid
SpaceCityKid Dec. 23 at 3:39 AM
$ABUS Bancel needs to come to grips with the fact that justice is coming
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 23 at 3:14 AM
Enter: $ABUS Calls Strike Price: $4 Expiry Date: JAN 16 2026 Buy in Price: $1.10 - $1.14 Sell Price: $1.78 Profit : +56% (Turn every $1 into $1.56) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
countingguy2006
countingguy2006 Dec. 22 at 11:11 PM
$ABUS Chances low for a settlement with MRNA and the closer it get to the trial dates, the chances get statistically lower. Approximately 1,400 days since the ABUS lawsuit. Trial is scheduled in about 75 days...I can't see a settlement before trial once it gets this deep in the calendar. Those hoping for a settlement over the last 4 years wasted hope. Hope is not a plan. If you saw how tight and stubborn Bancel was, like I saw in the almost 9 years of patent courts all the way until now, you would have seen that Bancel doesn't settle. He rather lose. The only thing that I hope is that a realistic chance that treble damages is in play as MRNA know that they were infringing from day one. The grim reaper is coming to collect from MRNA soon and the U.S. government in the end will be off the hook because they didn't give MRNA the license to steal. Tinkering with fractions of percentages to make ratios inconsistent and walk the legal plank with cost Moderna $$$BILLIONS
5 · Reply
Intergalactic_Portfolio
Intergalactic_Portfolio Dec. 22 at 10:28 PM
$ABUS After hours tape painting with Happy Meal money.
0 · Reply
Alfalcon
Alfalcon Dec. 22 at 8:55 PM
$ABUS Question for Team Bus. Should a settlement present itself? Odds are it will be marked confidential and sealed. How would that circumstance impact SP? Could we experience full potential of settlement news? I imagine same may hold true if jury decides?
3 · Reply
Grtgooglymoogly
Grtgooglymoogly Dec. 22 at 8:46 PM
$ABUS This is about when Ceo Lindsay (and Gline) could give long term longs a Christmas gift for being good and having patience, and sign a licensing deal.🎁
1 · Reply
SpaceCityKid
SpaceCityKid Dec. 22 at 7:14 PM
$ABUS Shorts are starting to rethink things....again
0 · Reply
CapitalismUSA
CapitalismUSA Dec. 22 at 6:30 PM
$ABUS $MRNA Moderna would be smart to settle with Arbutus during the holiday season when most are busy and not paying attention. But then again…they have proven to be very stupid
0 · Reply
Buqqets
Buqqets Dec. 22 at 6:29 PM
1 · Reply
DocPharm
DocPharm Dec. 22 at 5:34 PM
$ABUS 😉
2 · Reply